Zhengye Biotechnology Holding Limited (ZYBT) Revenue History
Annual and quarterly revenue from 2021 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ZYBT Revenue Growth
ZYBT Revenue Analysis (2021–2024)
As of May 9, 2026, Zhengye Biotechnology Holding Limited (ZYBT) generated trailing twelve-month (TTM) revenue of $0.
Looking at the longer-term picture, ZYBT's historical revenue data shows a 3-year CAGR of -4.5%. The company achieved its highest annual revenue of $260.3 million in 2022.
When compared to Healthcare sector peers including ATXG (-18.5% YoY), CLPS (+0.9% YoY), and TAOP (-15.1% YoY). Compare ZYBT vs ATXG →
ZYBT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ZYBTCurrent | $0 | - | - | 8.8% | |
 ATXG | $4M | -18.5% | -16.3% | -43.5% | |
 CLPS | $164M | +0.9% | +13.0% | -4.0% | |
 TAOP | $31M | -15.1% | +22.7% | -29.0% | |
 CNET | $15M | -66.6% | -23.3% | -24.3% | |
 AGRI | $67,887 | +2241.9% | - | -15322.6% |
ZYBT Historical Revenue Data (2021–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $186.4M | -12.0% | $91.3M | 49.0% | $16.4M | 8.8% |
| 2023 | $211.7M | -18.7% | $129.9M | 61.4% | $45.0M | 21.3% |
| 2022 | $260.3M | +21.6% | $153.5M | 59.0% | $65.8M | 25.3% |
| 2021 | $214.1M | - | $125.4M | 58.6% | $52.4M | 24.5% |
See ZYBT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZYBT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ZYBT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonZYBT — Frequently Asked Questions
Quick answers to the most common questions about buying ZYBT stock.
Is ZYBT's revenue growth accelerating or slowing?
ZYBT TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is ZYBT's long-term revenue growth rate?
Zhengye Biotechnology Holding Limited's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is ZYBT's revenue distributed by segment?
ZYBT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2021-2024 are available for download. Segment mix reveals concentration and diversification trends.